BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23246393)

  • 1. Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure.
    McCrindle BW; Manlhiot C; Cochrane A; Roberts R; Hughes M; Szechtman B; Weintraub R; Andrew M; Monagle P;
    J Am Coll Cardiol; 2013 Jan; 61(3):346-53. PubMed ID: 23246393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children.
    Monagle P; Cochrane A; Roberts R; Manlhiot C; Weintraub R; Szechtman B; Hughes M; Andrew M; McCrindle BW;
    J Am Coll Cardiol; 2011 Aug; 58(6):645-51. PubMed ID: 21798429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic complications and thromboprophylaxis across all three stages of single ventricle heart palliation.
    Manlhiot C; Brandão LR; Kwok J; Kegel S; Menjak IB; Carew CL; Chan AK; Schwartz SM; Sivarajan VB; Caldarone CA; Van Arsdell GS; McCrindle BW
    J Pediatr; 2012 Sep; 161(3):513-519.e3. PubMed ID: 22513267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation.
    Potter BJ; Leong-Sit P; Fernandes SM; Feifer A; Mayer JE; Triedman JK; Walsh EP; Landzberg MJ; Khairy P
    Int J Cardiol; 2013 Oct; 168(4):3940-3. PubMed ID: 23870650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No difference between aspirin and warfarin after extracardiac Fontan in a propensity score analysis of 475 patients.
    Iyengar AJ; Winlaw DS; Galati JC; Wheaton GR; Gentles TL; Grigg LE; Justo RN; Radford DJ; Attard C; Weintraub RG; Bullock A; Sholler GS; Celermajer DS; d'Udekem Y;
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):980-987. PubMed ID: 27229665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedure.
    Cheung YF; Chay GW; Chiu CS; Cheng LC
    Int J Cardiol; 2005 Jul; 102(3):509-13. PubMed ID: 16004898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post-Fontan procedure: Rationale and design of a prospective, randomized trial (the UNIVERSE study).
    Pina LM; Dong X; Zhang L; Samtani MN; Michelson AD; Justino H; Bonnet D; Harris KC; Jefferies J; McCrindle BW; Li JS
    Am Heart J; 2019 Jul; 213():97-104. PubMed ID: 31132584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboprophylaxis in Adults With Atrio-Pulmonary Fontan.
    Small AJ; Aboulhosn JA; Lluri G
    World J Pediatr Congenit Heart Surg; 2018 Sep; 9(5):504-508. PubMed ID: 30157726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commencement of warfarin therapy in children following the Fontan procedure.
    Crone E; Saliba N; George S; Hume E; Newall F; Jones S
    Thromb Res; 2013 Apr; 131(4):304-7. PubMed ID: 23399440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and predictors of haemostatic complications in 412 Fontan patients: their relation to anticoagulation and haemodynamics.
    Ohuchi H; Yasuda K; Miyazaki A; Ono S; Hayama Y; Negishi J; Noritake K; Mizuno M; Yamada O
    Eur J Cardiothorac Surg; 2015 Mar; 47(3):511-9. PubMed ID: 24699205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evolution of the Fontan operation and results in patients with single ventricles or mixed congenital malformations].
    Henaine R; Raisky O; Chavanis N; Aubert S; Di Filippo S; Ninet J
    Arch Mal Coeur Vaiss; 2005 Jan; 98(1):13-9. PubMed ID: 15724414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombosis prevention trial: compliance with warfarin treatment and investigation of a retained effect.
    Rudnicka AR; Ashby D; Brennan P; Meade T
    Arch Intern Med; 2003 Jun; 163(12):1454-60. PubMed ID: 12824095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for thromboprophylaxis in Fontan circulation: a meta-analysis.
    Alsaied T; Alsidawi S; Allen CC; Faircloth J; Palumbo JS; Veldtman GR
    Heart; 2015 Nov; 101(21):1731-7. PubMed ID: 26319122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of thromboembolic complications after the Fontan operation (total cavopulmonary anastomosis).
    Kaulitz R; Ziemer G; Rauch R; Girisch M; Bertram H; Wessel A; Hofbeck M
    J Thorac Cardiovasc Surg; 2005 Mar; 129(3):569-75. PubMed ID: 15746740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery.
    Khairy P; Fernandes SM; Mayer JE; Triedman JK; Walsh EP; Lock JE; Landzberg MJ
    Circulation; 2008 Jan; 117(1):85-92. PubMed ID: 18071068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of tricuspid atresia in the Fontan era.
    Sittiwangkul R; Azakie A; Van Arsdell GS; Williams WG; McCrindle BW
    Ann Thorac Surg; 2004 Mar; 77(3):889-94. PubMed ID: 14992893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of thrombosis and anticoagulation post Fontan surgery.
    Attard C; Huang J; Monagle P; Ignjatovic V
    Thromb Res; 2018 Dec; 172():204-213. PubMed ID: 29685556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibodies to the heparin/platelet factor 4 complex are an independent predictor of thrombotic complications following pediatric fontan surgery.
    Zhang R; Huang Y; Zhang M; Bai J; Liu J
    Clin Appl Thromb Hemost; 2012 Sep; 18(5):448-52. PubMed ID: 22679243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative trial of the use of antiplatelet and oral anticoagulant in thrombosis prophylaxis in patients undergoing total cavopulmonary operation with extracardiac conduit: echocardiographic, tomographic, scintigraphic, clinical and laboratory analysis.
    Pessotti CF; Jatene MB; Jatene IB; Oliveira PM; Succi FM; Moreira Vde M; Lopes RW; Pedra SR
    Rev Bras Cir Cardiovasc; 2014; 29(4):595-605. PubMed ID: 25714215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.